世界の硬化療法販売市場2020

◆英語タイトル:Global Sclerotherapy Sales Market Report 2020
◆商品コード:QYR21FB12815
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月
◆ページ数:149
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥684,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
QYResearch社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

QYリサーチ社の本調査レポートでは、世界の硬化療法市場について種類別(洗剤、浸透圧剤、化学刺激物)、用途別(静脈疾患、消化管出血、気管支胸膜瘻、嚢胞性疾患)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・硬化療法市場の概要
・世界の主要地域別硬化療法市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の硬化療法市場規模2015-2026:種類別(洗剤、浸透圧剤、化学刺激物)
・世界の硬化療法市場規模2015-2026:用途別(静脈疾患、消化管出血、気管支胸膜瘻、嚢胞性疾患)
・硬化療法のアメリカ市場規模2015-2020
・硬化療法のヨーロッパ市場規模2015-2020
・硬化療法の中国市場規模2015-2020
・硬化療法の日本市場規模2015-2020
・硬化療法の東南アジア市場規模2015-2020
・硬化療法のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・硬化療法の製造コスト分析
・販売チャネル、流通業者、顧客
・硬化療法の市場動向・機会・課題
・調査の結論
【レポートの概要】

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
Now more respected hospital minimally invasive surgical procedure, Sclerotherapy Treatment is relatively old. And there is a lot of shortcomings hardener. For example, it will be very painful in the course of treatment. But also produce pigmentation, or inflammation, swelling and other consequences, so I do not recommend using this method for the treatment of vascular malformations
Average industry gross margin is about 63.95%. However, due to the emergence of new treatments is not recommended investment.

Market Analysis and Insights: Global Sclerotherapy Market
The global Sclerotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Sclerotherapy Scope and Market Size
The global Sclerotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sclerotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Sclerotherapy market is segmented into
Detergents
Osmotic agents
Chemical irritants

Segment by Application, the Sclerotherapy market is segmented into
Venous disease
Gastrointestinal bleeding
Bronchopleural fistula
Cystic disease

The Sclerotherapy market is analysed and market size information is provided by regions (countries). Segment by Application, the Sclerotherapy market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Sclerotherapy Market Share Analysis
Sclerotherapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sclerotherapy business, the date to enter into the Sclerotherapy market, Sclerotherapy product introduction, recent developments, etc.

The major vendors covered:
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical

【レポートの目次】

1 Sclerotherapy Market Overview
1.1 Sclerotherapy Product Scope
1.2 Sclerotherapy Segment by Type
1.2.1 Global Sclerotherapy Sales by Type (2020-2026)
1.2.2 Detergents
1.2.3 Osmotic agents
1.2.4 Chemical irritants
1.3 Sclerotherapy Segment by Application
1.3.1 Global Sclerotherapy Sales Comparison by Application (2020-2026)
1.3.2 Venous disease
1.3.3 Gastrointestinal bleeding
1.3.4 Bronchopleural fistula
1.3.5 Cystic disease
1.4 Sclerotherapy Market Estimates and Forecasts (2015-2026)
1.4.1 Global Sclerotherapy Sales Growth Rate (2015-2026)
1.4.2 Global Sclerotherapy Revenue and Growth Rate (2015-2026)
1.4.3 Global Sclerotherapy Price Trends (2015-2026)

2 Sclerotherapy Estimate and Forecast by Region
2.1 Global Sclerotherapy Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Sclerotherapy Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Sclerotherapy Sales Market Share by Region (2015-2020)
2.2.2 Global Sclerotherapy Revenue Market Share by Region (2015-2020)
2.3 Global Sclerotherapy Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Sclerotherapy Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Sclerotherapy Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Sclerotherapy Estimates and Projections (2015-2026)
2.4.2 Europe Sclerotherapy Estimates and Projections (2015-2026)
2.4.3 China Sclerotherapy Estimates and Projections (2015-2026)
2.4.4 Japan Sclerotherapy Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Sclerotherapy Estimates and Projections (2015-2026)
2.4.6 India Sclerotherapy Estimates and Projections (2015-2026)
3 Global Sclerotherapy Competition Landscape by Players
3.1 Global Top Sclerotherapy Players by Sales (2015-2020)
3.2 Global Top Sclerotherapy Players by Revenue (2015-2020)
3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
3.4 Global Sclerotherapy Average Price by Company (2015-2020)
3.5 Manufacturers Sclerotherapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Sclerotherapy Players (Opinion Leaders)
4 Global Sclerotherapy Market Size by Type
4.1 Global Sclerotherapy Historic Market Review by Type (2015-2020)
4.1.1 Global Sclerotherapy Sales Market Share by Type (2015-2020)
4.1.2 Global Sclerotherapy Revenue Market Share by Type (2015-2020)
4.1.3 Global Sclerotherapy Price by Type (2015-2020)
4.2 Global Sclerotherapy Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Sclerotherapy Sales Forecast by Type (2021-2026)
4.2.2 Global Sclerotherapy Revenue Forecast by Type (2021-2026)
4.2.3 Global Sclerotherapy Price Forecast by Type (2021-2026)
5 Global Sclerotherapy Market Size by Application
5.1 Global Sclerotherapy Historic Market Review by Application (2015-2020)
5.1.1 Global Sclerotherapy Sales Market Share by Application (2015-2020)
5.1.2 Global Sclerotherapy Revenue Market Share by Application (2015-2020)
5.1.3 Global Sclerotherapy Price by Application (2015-2020)
5.2 Global Sclerotherapy Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Sclerotherapy Sales Forecast by Application (2021-2026)
5.2.2 Global Sclerotherapy Revenue Forecast by Application (2021-2026)
5.2.3 Global Sclerotherapy Price Forecast by Application (2021-2026)

6 United States Sclerotherapy Market Facts & Figures
6.1 United States Sclerotherapy Sales Market Share by Company (2015-2020)
6.2 United States Sclerotherapy Sales Market Share by Type (2015-2020)
6.3 United States Sclerotherapy Sales Market Share by Application (2015-2020)

7 Europe Sclerotherapy Market Facts & Figures
7.1 Europe Sclerotherapy Sales Market Share by Company (2015-2020)
7.2 Europe Sclerotherapy Sales Market Share by Type (2015-2020)
7.3 Europe Sclerotherapy Sales Market Share by Application (2015-2020)

8 China Sclerotherapy Market Facts & Figures
8.1 China Sclerotherapy Sales Market Share by Company (2015-2020)
8.2 China Sclerotherapy Sales Market Share by Type (2015-2020)
8.3 China Sclerotherapy Sales Market Share by Application (2015-2020)

9 Japan Sclerotherapy Market Facts & Figures
9.1 Japan Sclerotherapy Sales Market Share by Company (3015-3030)
9.2 Japan Sclerotherapy Sales Market Share by Type (2015-2020)
9.3 Japan Sclerotherapy Sales Market Share by Application (2015-2020)

10 Southeast Asia Sclerotherapy Market Facts & Figures
10.1 Southeast Asia Sclerotherapy Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Sclerotherapy Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Sclerotherapy Sales Market Share by Application (2015-2020)

11 India Sclerotherapy Market Facts & Figures
11.1 India Sclerotherapy Sales Market Share by Company (2015-2020)
11.2 India Sclerotherapy Sales Market Share by Type (2015-2020)
11.3 India Sclerotherapy Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Sclerotherapy Business
12.1 BTG
12.1.1 BTG Corporation Information
12.1.2 BTG Business Overview
12.1.3 BTG Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BTG Sclerotherapy Products Offered
12.1.5 BTG Recent Development
12.2 Kreussler
12.2.1 Kreussler Corporation Information
12.2.2 Kreussler Business Overview
12.2.3 Kreussler Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Kreussler Sclerotherapy Products Offered
12.2.5 Kreussler Recent Development
12.3 LGM Pharma
12.3.1 LGM Pharma Corporation Information
12.3.2 LGM Pharma Business Overview
12.3.3 LGM Pharma Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.3.4 LGM Pharma Sclerotherapy Products Offered
12.3.5 LGM Pharma Recent Development
12.4 Troikaa
12.4.1 Troikaa Corporation Information
12.4.2 Troikaa Business Overview
12.4.3 Troikaa Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Troikaa Sclerotherapy Products Offered
12.4.5 Troikaa Recent Development
12.5 Changan Tianyu group
12.5.1 Changan Tianyu group Corporation Information
12.5.2 Changan Tianyu group Business Overview
12.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Changan Tianyu group Sclerotherapy Products Offered
12.5.5 Changan Tianyu group Recent Development
12.6 Bioniche Pharma Group Ltd
12.6.1 Bioniche Pharma Group Ltd Corporation Information
12.6.2 Bioniche Pharma Group Ltd Business Overview
12.6.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
12.6.5 Bioniche Pharma Group Ltd Recent Development
12.7 Omega Pharmaceuticals
12.7.1 Omega Pharmaceuticals Corporation Information
12.7.2 Omega Pharmaceuticals Business Overview
12.7.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Omega Pharmaceuticals Sclerotherapy Products Offered
12.7.5 Omega Pharmaceuticals Recent Development
12.8 Angiodynamics
12.8.1 Angiodynamics Corporation Information
12.8.2 Angiodynamics Business Overview
12.8.3 Angiodynamics Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Angiodynamics Sclerotherapy Products Offered
12.8.5 Angiodynamics Recent Development
12.9 ENDO-FLEX
12.9.1 ENDO-FLEX Corporation Information
12.9.2 ENDO-FLEX Business Overview
12.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.9.4 ENDO-FLEX Sclerotherapy Products Offered
12.9.5 ENDO-FLEX Recent Development
12.10 MTW ENDOSKOPIE
12.10.1 MTW ENDOSKOPIE Corporation Information
12.10.2 MTW ENDOSKOPIE Business Overview
12.10.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.10.4 MTW ENDOSKOPIE Sclerotherapy Products Offered
12.10.5 MTW ENDOSKOPIE Recent Development
12.11 Cook Medical
12.11.1 Cook Medical Corporation Information
12.11.2 Cook Medical Business Overview
12.11.3 Cook Medical Sclerotherapy Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cook Medical Sclerotherapy Products Offered
12.11.5 Cook Medical Recent Development

13 Sclerotherapy Manufacturing Cost Analysis
13.1 Sclerotherapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sclerotherapy
13.4 Sclerotherapy Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sclerotherapy Distributors List
14.3 Sclerotherapy Customers

15 Market Dynamics
15.1 Sclerotherapy Market Trends
15.2 Sclerotherapy Opportunities and Drivers
15.3 Sclerotherapy Market Challenges
15.4 Sclerotherapy Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Sclerotherapy Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Sclerotherapy Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Sclerotherapy Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Sclerotherapy Sales (K Pcs) by Region (2015-2020)
Table 5. Global Sclerotherapy Sales Market Share by Region (2015-2020)
Table 6. Global Sclerotherapy Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Sclerotherapy Revenue Share by Region (2015-2020)
Table 8. Global Sclerotherapy Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Sclerotherapy Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Sclerotherapy Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Sclerotherapy Revenue Share Forecast by Region (2021-2026)
Table 12. Global Sclerotherapy (K Pcs) of Key Companies (2015-2020)
Table 13. Global Sclerotherapy Sales Share by Company (2015-2020)
Table 14. Global Sclerotherapy Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Sclerotherapy Revenue Share by Company (2015-2020)
Table 16. Global Sclerotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
Table 17. Global Sclerotherapy Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Sclerotherapy Manufacturing Sites and Area Served
Table 19. Manufacturers Sclerotherapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Sclerotherapy Players
Table 22. Global Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 23. Global Sclerotherapy Sales Share by Type (2015-2020)
Table 24. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Sclerotherapy Price (K Pcs) by Type (2015-2020)
Table 26. Global Sclerotherapy Sales Share by Type (2021-2026)
Table 27. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Sclerotherapy Revenue Share by Type (2021-2026)
Table 29. Global Sclerotherapy Price (K Pcs) by Type (2021-2026)
Table 30. Global Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 31. Global Sclerotherapy Sales Share by Application (2015-2020)
Table 32. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Sclerotherapy Price (K Pcs) by Application (2015-2020)
Table 34. Global Sclerotherapy Sales (K Pcs) by Application (2021-2026)
Table 35. Global Sclerotherapy Sales Share by Application (2021-2026)
Table 36. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Sclerotherapy Revenue Share by Application (2021-2026)
Table 38. Global Sclerotherapy Price (K Pcs) by Application (2021-2026)
Table 39. United States Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 40. United States Sclerotherapy Sales Market Share by Company (2015-2020)
Table 41. United States Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 42. United States Sclerotherapy Sales Market Share by Type (2015-2020)
Table 43. United States Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 44. United States Sclerotherapy Sales Market Share by Application (2015-2020)
Table 45. Europe Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Sclerotherapy Sales Market Share by Company (2015-2020)
Table 47. Europe Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Sclerotherapy Sales Market Share by Type (2015-2020)
Table 49. Europe Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Sclerotherapy Sales Market Share by Type (2015-2020)
Table 51. China Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 52. China Sclerotherapy Sales Market Share by Company (2015-2020)
Table 53. China Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 54. China Sclerotherapy Sales Market Share by Type (2015-2020)
Table 55. China Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 56. China Sclerotherapy Sales Market Share by Application (2015-2020)
Table 57. Japan Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Sclerotherapy Sales Market Share by Company (2015-2020)
Table 59. Japan Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Sclerotherapy Sales Market Share by Type (2015-2020)
Table 61. Japan Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Sclerotherapy Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Sclerotherapy Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Sclerotherapy Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Sclerotherapy Sales Market Share by Application (2015-2020)
Table 69. India Sclerotherapy Sales (K Pcs) by Company (2015-2020)
Table 70. India Sclerotherapy Sales Market Share by Company (2015-2020)
Table 71. India Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 72. India Sclerotherapy Sales Market Share by Type (2015-2020)
Table 73. India Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 74. India Sclerotherapy Sales Market Share by Application (2015-2020)
Table 75. BTG Corporation Information
Table 76. BTG Description and Business Overview
Table 77. BTG Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. BTG Sclerotherapy Product
Table 79. BTG Recent Development
Table 80. Kreussler Corporation Information
Table 81. Kreussler Description and Business Overview
Table 82. Kreussler Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Kreussler Sclerotherapy Product
Table 84. Kreussler Recent Development
Table 85. LGM Pharma Corporation Information
Table 86. LGM Pharma Description and Business Overview
Table 87. LGM Pharma Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. LGM Pharma Sclerotherapy Product
Table 89. LGM Pharma Recent Development
Table 90. Troikaa Corporation Information
Table 91. Troikaa Description and Business Overview
Table 92. Troikaa Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Troikaa Sclerotherapy Product
Table 94. Troikaa Recent Development
Table 95. Changan Tianyu group Corporation Information
Table 96. Changan Tianyu group Description and Business Overview
Table 97. Changan Tianyu group Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Changan Tianyu group Sclerotherapy Product
Table 99. Changan Tianyu group Recent Development
Table 100. Bioniche Pharma Group Ltd Corporation Information
Table 101. Bioniche Pharma Group Ltd Description and Business Overview
Table 102. Bioniche Pharma Group Ltd Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Bioniche Pharma Group Ltd Sclerotherapy Product
Table 104. Bioniche Pharma Group Ltd Recent Development
Table 105. Omega Pharmaceuticals Corporation Information
Table 106. Omega Pharmaceuticals Description and Business Overview
Table 107. Omega Pharmaceuticals Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Omega Pharmaceuticals Sclerotherapy Product
Table 109. Omega Pharmaceuticals Recent Development
Table 110. Angiodynamics Corporation Information
Table 111. Angiodynamics Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Angiodynamics Description and Business Overview
Table 113. Angiodynamics Sclerotherapy Product
Table 114. Angiodynamics Recent Development
Table 115. ENDO-FLEX Corporation Information
Table 116. ENDO-FLEX Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. ENDO-FLEX Description and Business Overview
Table 118. ENDO-FLEX Sclerotherapy Product
Table 119. ENDO-FLEX Recent Development
Table 120. MTW ENDOSKOPIE Corporation Information
Table 121. MTW ENDOSKOPIE Description and Business Overview
Table 122. MTW ENDOSKOPIE Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. MTW ENDOSKOPIE Sclerotherapy Product
Table 124. MTW ENDOSKOPIE Recent Development
Table 125. Cook Medical Corporation Information
Table 126. Cook Medical Description and Business Overview
Table 127. Cook Medical Sclerotherapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Cook Medical Sclerotherapy Product
Table 129. Cook Medical Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Sclerotherapy Distributors List
Table 133. Sclerotherapy Customers List
Table 134. Sclerotherapy Market Key Trends
Table 135. Sclerotherapy Key Opportunities and Drivers
Table 136. Sclerotherapy Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sclerotherapy Market Share by Application in 2020 & 2026
Figure 6. Venous disease Examples
Figure 7. Gastrointestinal bleeding Examples
Figure 8. Bronchopleural fistula Examples
Figure 9. Cystic disease Examples
Figure 10. Global Sclerotherapy Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Sclerotherapy Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Sclerotherapy Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Sclerotherapy Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Sclerotherapy Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Sclerotherapy Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Sclerotherapy Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Sclerotherapy Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Sclerotherapy Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Sclerotherapy Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Sclerotherapy Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Sclerotherapy Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Sclerotherapy Players Market Share by Revenue in Sclerotherapy 2015 & 2019
Figure 28. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Sclerotherapy Revenue Share by Type (2015-2020)
Figure 30. Global Sclerotherapy Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Sclerotherapy Revenue Share by Application (2015-2020)
Figure 32. Global Sclerotherapy Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Sclerotherapy Sales Market Share by Type in 2019
Figure 34. United States Sclerotherapy Sales Market Share by Type in 2019
Figure 35. Europe Sclerotherapy Sales Market Share by Company in 2019
Figure 36. Europe Sclerotherapy Sales Market Share by Type in 2019
Figure 37. Europe Sclerotherapy Sales Market Share by Application in 2019
Figure 38. China Sclerotherapy Sales Market Share by Company in 2019
Figure 39. China Sclerotherapy Sales Market Share by Type in 2019
Figure 40. China Sclerotherapy Sales Market Share by Application in 2019
Figure 41. Japan Sclerotherapy Sales Market Share by Company in 2019
Figure 42. Japan Sclerotherapy Sales Market Share by Type in 2019
Figure 43. Japan Sclerotherapy Sales Market Share by Application in 2019
Figure 44. Southeast Asia Sclerotherapy Sales Market Share by Company in 2019
Figure 45. Southeast Asia Sclerotherapy Sales Market Share by Type in 2019
Figure 46. Southeast Asia Sclerotherapy Sales Market Share by Application in 2019
Figure 47. India Sclerotherapy Sales Market Share by Company in 2019
Figure 48. India Sclerotherapy Sales Market Share by Type in 2019
Figure 49. India Sclerotherapy Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Sclerotherapy
Figure 52. Manufacturing Process Analysis of Sclerotherapy
Figure 53. Sclerotherapy Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


【掲載企業】

BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の硬化療法販売市場2020]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆